See the latest news and media coverage for Pfizer. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company
pfizer.comLast updated
In short: Pfizer raised its 2026 revenue guidance, reported strong Q2 results, and won regulatory approvals for its updated COVID-19 vaccine.
The partnership aims to accelerate R&D of 12 early-stage oncology programs, including ADCs and multi-specific antibodies, combining Pfizer's global expertise with Innovent's discovery capabilities.
The company emphasizes its commitment to patients and delivering breakthroughs that change lives.
The study involves a potential first-in-class IL4/13 and TSLP trispecific antibody for atopic dermatitis. It supports advancing a broad program for Type 2 inflammatory conditions.
The company delivered patient-changing breakthroughs and anticipates 2026 with focus and commitment.
Pfizer (NYSE:PFE) Chairman and Chief Executive Officer Albert Bourla said the drugmaker has...
The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania.
Pfizer said the discontinuation took effect from September 7, 2026, following a decision by Pfizer Inc, USA, to discontinue the manufacture of Minipress XL.
The goal is to see if the drug helps with weight loss while staying safe, a key step as Pfizer tries to build a bigger...
Track Pfizer and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Pfizer and other trending companies.